Sign In
Buy LLY
$1,185.71
-6.23 (-0.523%)
At Close: Aug 07, 2026
Eli Lilly first-generation Alzheimer's drug did not slow cognitive decline
03:34am, Thursday, 09'th Mar 2023
Eli Lilly and Co (NYSE:LLY)'s early-generation Alzheimer's drug, solanezumab, did not slow cognitive decline in patients treated before they showed symptoms, according to the results of a large trial.
Eli Lilly Alzheimer's treatment solanezumab failed to slow disease progression
11:34pm, Wednesday, 08'th Mar 2023
Solanezumab's failure is a blow to efforts to treat Alzheimer's in people who have not yet shown clinical symptoms.
Lilly's drug aimed at preventing Alzheimer's fails
05:54pm, Wednesday, 08'th Mar 2023
Eli Lilly & Co. said late Wednesday that a drug aimed at preventing Alzheimer's disease before symptoms start has failed to slow down cognitive decline in healthy older adults at risk of developing th
Eli Lilly's Insulin Decision Puts Others in Hot Seat
05:30am, Wednesday, 08'th Mar 2023
The drugmaker's plan moves the spotlight to industry middlemen, who face a barrage of investigations.
Lilly's (LLY) Verzenio Gets FDA Nod for Expanded Breast Cancer
12:02pm, Tuesday, 07'th Mar 2023
Eli Lilly (LLY) announces FDA approval of label expansion of Verzenio (abemaciclib), in combination with endocrine therapy, for treating HR+, HER2-, node-positive and high-risk early breast cancer.
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
10:32am, Tuesday, 07'th Mar 2023
Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
WW Stock Soars As Telehealth Deal Opens Up Hot Obesity Drug Market
07:12am, Tuesday, 07'th Mar 2023
Former WeightWatchers is entering clinical weight management. WW stock surged.
7 High-Growth Stocks for ESG-Oriented Investors
11:19am, Sunday, 05'th Mar 2023
Generally, a perception exists that supporting environmental, social, and governance ( ESG ) initiatives may lead to expansion and profitability erosion, though the enthusiasm toward the following hig
AI Stock Headlines 5 Leaders Flashing Buy Signals As Market Rally Gains Steam
08:59am, Saturday, 04'th Mar 2023
Arista Networks, which keeps popping up on lists of top AI stocks, leads this weekend's watch list of 5 stocks near buy points. The post AI Stock Headlines 5 Leaders Flashing Buy Signals As Market Ral
Best Buy, Eli Lilly, Salesforce: Stocks That Defined the Week
06:07pm, Friday, 03'rd Mar 2023
Here are seven major companies whose stocks moved on the week's news.
NVS vs. LLY: Which Stock Is the Better Value Option?
12:48pm, Friday, 03'rd Mar 2023
NVS vs. LLY: Which Stock Is the Better Value Option?
2 Safe Stocks to Buy Hand Over Fist in 2023
05:58am, Friday, 03'rd Mar 2023
Established companies in industries less vulnerable to cyclical headwinds can offer a measure of safety in a market storm.
5 Best and Worst Performing Mega-Cap Stocks in February 2023
10:55pm, Thursday, 02'nd Mar 2023
After a strong performance in January, the stock market lost pace in the second month of the year.
2 Stocks Down 12% or More This Year to Buy Hand Over Fist
09:55am, Thursday, 02'nd Mar 2023
Investors might want to act fast before it's too late.
Eli Lilly CEO on slashing insulin prices, approval timelines for weight-loss and Alzheimer's drugs
05:09pm, Wednesday, 01'st Mar 2023
CNBC's Meg Tirrell and David Ricks, Eli Lilly CEO, joins 'Closing Bell: Overtime' to discuss the company's decision to slash insulin prices. He also discusses his economic outlook and the timeline for
